JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Periorbital rejuvenation: a safe subcutaneous approach to forehead, eyebrow, and orbicularis oculis muscle mobilization.

BACKGROUND: Periorbital rejuvenation constitutes a common and much demanded claim. With aging face, fascial attachments and ligamentous supports become attenuated, and therefore, skin, orbicular muscle, malar fat and lateral eyebrow descend in middle-age women. Conventional facelift and standard blepharoplasty does not give an effective periorbital rejuvenation.

METHODS: This technique was applied in 142 patients from 1999 to 2006 to treat periorbital aging. All patients were 35 to 55 years old, and 94.5% were female. Through an incision located in the hair line or inside the temporal portion of scalp, a wide subcutaneous dissection of temporal, forehead and eyelid areas was done. This allows undermining and suspension of the orbicularis oculis muscle with partial denervation and the concomitant treatment of crow's feet, lateral muscular cantoplasty, elevation of the malar fat, superolateral traction of the eyebrow and resection of excess skin. Blepharoplasty or a conventional facelift was included if necessary.

RESULTS: A total of 130 patients (91%) presented satisfactory results. In 16 patients (11 %) , partial infection of the temporal wound was detected; in other 12 (9 %), asymmetry of eyebrows was present, of which 9 (75%) corrected spontaneously after 3 months and in other 3 (25 %), a reoperation was necessary. No major complications were observed.

CONCLUSIONS: This technique allows a rational correction of all affected periorbital tissues, including forehead, eyebrow, eyelids, canthal ligaments, orbicularis muscle, malar fat and both periorbital and cheek skin with superior and superolateral vectors of traction. This is a safe and easy technique.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app